DENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the launch of Cleerly ISCHEMIA, which recently received U.S.

This unexpected ability opens the door for scientists to stimulate cellular mitosis and improve heart function after an attack.

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The World Health Organization reports that ischaemic heart disease, also known as coronary artery disease, is the leading ...

Allopurinol, a drug commonly used to treat gout, provided no benefit in terms of reducing cardiovascular (CV) events in patients with ischemic heart disease, new randomized trial results show.

Please provide your email address to receive an email when new articles are posted on . “Remarkably, we found that all of them were independent long-term risk factors for ischemic heart disease, even ...

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced a key publication in the ...

A stress test measures how well your heart works when put under stress. It is ordered to assess exercise tolerance, see if your heart can respond to demands, or test if heart medications are working.